Home / Stock ratings / Robotics and Automation Stocks / CGNX

Stock rating

Cognex Corp (CGNX) Stock Rating & Analysis

As of November 19, 2026, MELANY rates Cognex Corp 60 out of 100 (Hold). Its highest factor score is earnings track record at 99, and its lowest is price momentum at 28.

MELANY ratingRated 2026-11-19

CGNX · composite score

60/100
Hold
Nov 19
Rating date
Live price in the app →
Quality78
Momentum28
Risk-adjusted45
Source basis SEC filings and live market dataDated snapshot

Why CGNX scores 60/100

CGNX's 8 factor scores run from 28 to 99, and 3 of them sit above its composite of 60. Here is how CGNX breaks down.

Valuation47/100

Whether the price looks cheap or expensive against earnings, growth, and peers.

  • Forward P/E 23.7x, earnings growth accelerating
Business quality78/100

Margins, returns on capital, and balance-sheet strength.

  • Gross margin 70%
Price momentum28/100

Direction and relative strength of the recent share-price trend.

Earnings track record99/100

History of beating or missing estimates, and where estimates are heading.

  • Beat EPS estimates 4 of last 4 quarters
  • Avg EPS beat +15%
Analyst sentiment83/100

What Wall Street price targets and revisions are signalling.

  • Analyst targets 46% upside
Catalyst setup36/100

Near-term events that could move the stock.

Risk-adjusted profile45/100

Upside weighed against volatility and drawdown risk.

Macro fit50/100

How the current rate and market regime suits this kind of company.

How CGNX compares

As of November 19, 2026, Cognex Corp ranks 6th of 14 in Robotics and Automation Stocks, where the average score is 58.

All stock rating pages.

Key risks for CGNX

  • Weak price momentum, trend not yet confirmed, may need more time to set up

Sector and theme context

Cognex Corp sits in the Technology sector theme, which MELANY currently rates 41/100 for strength. Theme strength feeds CGNX's momentum and catalyst factors above.

Tracking CGNX

Cognex Corp rates Hold right now, so MELANY is not flagging a fresh entry. Add CGNX to a watchlist in the app to follow its rating; an alert the moment it changes is part of Pro, free for 30 days.

How MELANY rates CGNX

MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Cognex Corp's 60/100 reflects mature factor weighting for its profile.

Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.

Frequently asked questions about CGNX

Is Cognex Corp (CGNX) a buy?

As of 2026-11-19, MELANY rated Cognex Corp Hold with a composite score of 60/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.

How does CGNX rank against similar companies?

As of November 19, 2026, Cognex Corp ranks 6th of 14 in MELANY's Robotics and Automation Stocks list, where the average score is 58. Among the other names in the list, the highest scores belong to ZBRA (67) and TER (65).

Should I buy Cognex Corp stock?

That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Cognex Corp (CGNX) Hold with a composite of 60/100 as of 2026-11-19. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.

What is the CGNX stock price forecast?

MELANY does not publish price targets or forecasts for CGNX. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 60/100 across eight factors for Cognex Corp, and re-scores automatically as new price, earnings, and fundamental data arrive. What it does read for CGNX as of 2026-11-19: its analyst sentiment factor is 83/100 (Analyst targets 46% upside), and its price momentum factor is 28/100.

Is CGNX stock overvalued or undervalued?

MELANY's valuation factor currently reads 47/100 for Cognex Corp, where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives CGNX's read.

What price should I buy CGNX at?

MELANY is not flagging a fresh entry for CGNX at its current Hold rating, so there is no entry zone to publish right now. Add CGNX to a watchlist in the app to follow it; an alert the moment the rating changes is part of Pro, free for 30 days.

What are the risks of buying CGNX stock?

The top risks MELANY currently flags for Cognex Corp: Weak price momentum, trend not yet confirmed, may need more time to set up. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.

Is Cognex Corp a good long-term investment?

For long-term durability the two factors that matter most are business quality, which MELANY scores 78/100 for Cognex Corp, and earnings track record, at 99/100. The 60/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.

Will CGNX stock go up?

Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 28/100 for CGNX right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.

How current is this CGNX rating?

The rating on this page is a snapshot of MELANY's read as of 2026-11-19, and the score is not recomputed on this page. MELANY re-scores CGNX as new price, earnings, and fundamental data arrive; the current rating and the live price are in the app (the rating is part of Pro, free for 30 days).

How this rating works

Market Eyes Live

Every rating graded in public, CGNX included

MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.

Get the free iOS app Create a free account on the web Free account, no card. Pro: 30 days free, then $9.99 a month.